BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 546589)

  • 1. High affinity dopamine receptors (D3) in rat brain.
    Titeler M; List S; Seeman P
    Commun Psychopharmacol; 1979; 3(6):411-20. PubMed ID: 546589
    [No Abstract]   [Full Text] [Related]  

  • 2. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
    Piercey MF; Walker EL; Feldpausch DL; Camacho-Ochoa M
    Neurosci Lett; 1996 Nov; 219(2):138-40. PubMed ID: 8971799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of [3H]pergolide mesylate to dopamine receptors of mammalian brains.
    Wong DT; Bymaster FP; Lane PT; Kau D; Bach NJ; Kornfeld EC
    Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):195-210. PubMed ID: 7444158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity 3H-dopamine receptors (D3 sites) in human and rat brain.
    List S; Titeler M; Seeman P
    Biochem Pharmacol; 1980 Jun; 29(11):1621-2. PubMed ID: 7396995
    [No Abstract]   [Full Text] [Related]  

  • 6. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraventricular injection of neurotensin reduces the binding of dopamine D-2 receptors in the rat forebrain.
    von Euler G; Meister B; Hökfelt T; Fuxe K
    Acta Physiol Scand; 1989 Oct; 137(2):309-10. PubMed ID: 2618764
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state.
    Sibley DR; Mahan LC; Creese I
    Mol Pharmacol; 1983 Mar; 23(2):295-302. PubMed ID: 6835198
    [No Abstract]   [Full Text] [Related]  

  • 10. Agonist interactions with dopamine receptors: focus on radioligand-binding studies.
    Creese I; Sibley DR; Leff SE
    Fed Proc; 1984 Oct; 43(13):2779-84. PubMed ID: 6383871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3H-Apomorphine interactions with dopamine receptors in calf brain.
    Thal L; Creese I; Snyder SH
    Eur J Pharmacol; 1978 Jun; 49(3):295-9. PubMed ID: 658143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.
    Creese I; Prosser T; Synder SH
    Life Sci; 1978 Aug; 23(5):495-9. PubMed ID: 692273
    [No Abstract]   [Full Text] [Related]  

  • 13. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three classes of dopamine receptor (D-2, D-3, D-4) identified by binding studies with 3H-apomorphine and 3H-domperidone.
    Sokoloff P; Martres MP; Schwartz JC
    Naunyn Schmiedebergs Arch Pharmacol; 1980; 315(2):89-102. PubMed ID: 7207647
    [No Abstract]   [Full Text] [Related]  

  • 15. Conversion of dopamine D1 receptors from high to low affinity for dopamine.
    Seeman P; Ulpian C; Grigoriadis D; Pri-Bar I; Buchman O
    Biochem Pharmacol; 1985 Jan; 34(1):151-4. PubMed ID: 3881100
    [No Abstract]   [Full Text] [Related]  

  • 16. A mosaic-like distribution of dopamine receptors in rat neostriatum and its relationship to striosomes.
    Loopuijt LD; Sebens JB; Korf J
    Brain Res; 1987 Mar; 405(2):405-8. PubMed ID: 3567618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of 3H-apomorphine binding by dopamine and bromocriptine.
    Robertson HA
    Eur J Pharmacol; 1980 Jan; 61(2):209-11. PubMed ID: 7353592
    [No Abstract]   [Full Text] [Related]  

  • 18. Stereospecific binding of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene to rat brain dopamine receptors [proceedings].
    Davis A; Poat JA; Woodruff GN
    Biochem Soc Trans; 1979 Feb; 7(1):147-8. PubMed ID: 437261
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudo non-competitive agonist interactions with dopamine receptors.
    Sibley DR; Creese I
    Eur J Pharmacol; 1980 Jul; 65(1):131-3. PubMed ID: 7398773
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacology of [3H]apomorphine binding to bovine brain tissue.
    Arana GW; Baldessarini RJ; Harding M
    Biochem Pharmacol; 1981 Dec; 30(23):3171-9. PubMed ID: 7317102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.